The Patent Finder
US

Ready-To-Use Bivalirudin Compositions

US 7,803,762 In force
OverviewFamilyAssignmentsSources & methods

Term ends Aug 20, 2029 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,713,928), so the cap could be lower.

Held by Sandoz Inc.
Filed Aug 20, 2009 as application 12/545,036 · Granted Sep 28, 2010
Base term, 20 years from filing
Today
20 years from filing
2009 2029
Clock starts
Aug 20, 2009
Term ends
Aug 20, 2029
Granted
Sep 28, 2010
base term fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,713,928, to Aug 20, 2029. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 20, 2009, when this application, 12/545,036, was filedAug 20, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,713,928)resolves to Aug 20, 2029, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 20, 2029Medium confidence

This family

US 7,803,762this patent
Aug 2029
Aug 2029
Application 12/856,088Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 21, 2009
reel/frame not recorded
Krishna, Gopal, DR.; Motheram, Rajeshwar, DR.; Palepu, Nagesh, DR.; Shah, Praful, DR.The Medicines ComapnyAssignment of Assignor's Interest
Aug 21, 2009
reel/frame not recorded
Krishna, Gopal, DR.; Motheram, Rajeshwar, DR.; Palepu, Nagesh, DR.; Shah, Praful, DR.Eagle Pharmaceuticals, Inc.Assignment of Assignor's Interest
Aug 21, 2009
Reel 23126, frame 758
Palepu, Nagesh, DR.; Motheram, Rajeshwar, DR.; Shah, Praful, DR.; Krishna, Gopal, DR.The Medicines Comapny; Eagle Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 26, 2017
Reel 41095, frame 554
Eagle Pharmaceuticals, Inc.JPMorgan Chase Bank, N.A., as Administrative AgentSecurity Interest
Dec 17, 2018
Reel 47794, frame 61
The Medicines CompanySandoz Inc.Assignment of Assignor's Interest
Apr 1, 2025
Reel 70703, frame 524
JPMorgan Chase Bank, N.A., as Administrative AgentEagle Pharmaceuticals, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited